Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAgronomics Regulatory News (ANIC)

Share Price Information for Agronomics (ANIC)

Share Price is delayed by 15 minutes
Get Live Data
6.55    0.00 (0.00%)
Bid:
6.20
Ask:
6.90
Spread: 0.70 (11.29%)
Market Cap: £70.42m
ANIC Live PriceLast checked at - London Stock Exchange

Intraday Agronomics Share Chart

Net Asset Value calculation as at 31 March 2026

18 May 2026 07:00

RNS Number : 5690E
Agronomics Limited
18 May 2026
Β 

Β 

18 May 2026

Agronomics Limited

("Agronomics" or the "Company")

Net Asset Value calculation as atΒ 31 March 2026

Agronomics LimitedΒ (AIM:ANIC), a leading listed company in the field of clean food, announces that its unaudited Net Asset Value per share ("NAV") calculation as at closing onΒ 31 March 2026Β wasΒ 13.12 penceΒ per share, a 4.8% decrease fromΒ 13.78 penceΒ per share atΒ 31 December 2025. Net Assets stand atΒ Β£139 million, including investments ofΒ Β£138 millionΒ and uninvested cash and short-term deposits ofΒ Β£1.9 million.

The share price ofΒ 6.32 penceΒ at 31 March 2026Β represents a discount of 52% to the NAV per share on the same date. The average discount to NAV per share over the last 12-month period was 50%. Under IFRS, the Company's unquoted investments are generally carried at cost or the most recent priced funding round.

The Β£1.3 million decrease in the Company's NAV during the quarter which relates primarily to the following:

- An unrealised FX gain of Β£2.1 million following revaluation of investments to month end spot rate, where we hold certain of our investments in USD, EUR and AUD, due to positive movements in these currencies against the Company's reporting currency of Pound Sterling in the quarter;

- Unrealised fair value losses on the investment held in Solar Foods Oy, with its shares traded on the Nasdaq First North Growth Exchange, of Β£0.12 million; and

- Cash balances reduced by Β£0.3 million relating to ongoing running costs. This is offset by interest income earned during the quarter, with Β£10k cash interest received and Β£35k loan note interest income accrued.

Cash and deposit balances at 31 March 2026 were Β£1.9 million (31 December 2025: Β£2.1 million)

During the period, no fees were payable or accrued in accordance with the Shellbay Investments Limited Agreement. Shellbay's fees are only payable when there is an annual increase in the NAV; further details are included in the 2025 annual report.

Investment Portfolio review

During the 3-month period to 31 March 2026, two portfolio companies successfully completed fundraises:

Β· 15 January 2026 - Agronomics made an additional investment of AU$3 million (c.Β£1,468,860) in All G Co Holdings Pty Limited via a Note Purchase Agreement, as part of a minimum AU$10 million funding round. The consideration was satisfied in full by the issue of 10,026,375 new Ordinary Shares of Agronomics at 14.65 pence per share. Capital raised will be used primarily to scale up commercial production, advance additional regulatory submissions, strengthen the company's IP portfolio, and expand commercial activities across Asia and Europe.

Β· 19 March 2026 - Tropic Biosciences UK Limited closed a US$105 million Series C financing round, co-led by Forbion through its Bioeconomy Fund and Corteva through its Corteva Catalyst investment platform, with participation from Just Climate, IQ Capital, ABN AMRO, Invest International, Temasek, Five Seasons Ventures, Sucden Ventures, Genoa Ventures and Polaris Partners. The capital will be used to accelerate the global commercial scale up of Tropic's banana and rice portfolios, advance the pipeline of their climate-resilient crops and to expand large-scale plant production.

The following key milestone was achieved by our portfolio company during the 3-month period:

Β· 25 March 2026 - Clean Food Group announced the commercial launch of CLEANOilβ„’, its biotechnology-derived ingredient platform for the beauty industry, ahead of its debut at in-cosmetics Global in Paris. The launch, achieved through collaboration with beauty manufacturer THG Labs, marks the progression of CLEANOilβ„’ from concept to commercial reality.

Β 

Jim Mellon, Executive Chair of Agronomics, commented:

"The first quarter of the year was an encouraging reminder that the clean food sector continues to produce companies capable of attracting serious, long-term capital. While much of the wider market remains cautious, the businesses with credible technology and a clear route to commercialisation are still finding strong support. During the period, Tropic's US$ 105 million Series C demonstrated the appetite that exists for proven, scalable platforms addressing genuine challenges in global food and agriculture, while Clean Food Group's commercial launch of CLEANOilβ„’ with THG Labs represents a concrete step from development into the market. These are tangible, operational developments, and they reinforce our belief that the companies best positioned to lead are those translating scientific capability into commercial outcomes."

Β 

Β 

Unaudited to 31 March 2026

Β£

Current Assets

Β 

Β 

Β 

Investments

136,793,745

Β 

Uninvested cash and deposits

1,872,462

Β 

Trade and other receivables

88,627

Current Liabilities

Β 

Β 

Β 

Trade and other creditors

(105,905)

Net Assets

Β 

138,648,929

Capital and Reserves

Β 

Β 

Β 

Share capital

1,056

Β 

Share premium

143,113,652

Β 

Retained earnings

(4,465,779)

Net assets

Β 

138,648,929

Shares in Issue

Β 

Β 

Net Asset Value per share

Β 

13.12 pence

Β 

The quoted investments within the portfolio are valued under IFRS at bid price.

This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) No. 596/2014, as it forms part of UK Domestic Law by virtue of the European Union (Withdrawal) Act 2018. Upon the publication of this announcement, this inside information is now considered to be in the public domain.

About Agronomics

Agronomics is a leading London-listed company focusing on investment opportunities within the field of clean food. The Company has established a portfolio of over 20 companies in this rapidly advancing sector. It seeks to invest in companies owning technologies with defensible intellectual property that offer new ways of producing food and materials with a focus on products historically derived from animals. These technologies are driving a major disruption in agriculture, offering solutions to improve sustainability, as well as addressing human health, animal welfare and environmental damage. This disruption will decouple supply chains from the environment and animals and improve food security for the world's expanding population. A full list of Agronomics' portfolio companies is available at https://agronomics.im/.

For further information please contact:

Agronomics Limited

Beaumont Cornish Limited

Canaccord Genuity Limited

Cavendish Capital Markets Limited

33Seconds Limited

Β 

The Company

Β 

Nomad

Joint Broker

Joint Broker

Public Relations

Jim Mellon

Denham Eke

Roland Cornish

James Biddle

Andrew Potts

Harry Pardoe

Β 

Giles Balleny

Michael Johnson

Β 

Jack Ferris

Amber Carr

Β 

+44 (0) 1624 639396

info@agronomics.im

+44 (0) 207 628 3396

+44 (0) 207 523 8000

+44 (0) 207 397 8900

agronomics@33seconds.co

Β 

Nominated Adviser Statement

Beaumont Cornish Limited ("Beaumont Cornish"), is the Company's Nominated Adviser and is authorised and regulated in the United Kingdom by the Financial Conduct Authority. Beaumont Cornish's responsibilities as the Company's Nominated Adviser, including a responsibility to advise and guide the Company on its responsibilities under the AIM Rules for Companies and AIM Rules for Nominated Advisers, are owed solely to the London Stock Exchange. Beaumont Cornish is not acting for and will not be responsible to any other persons for providing protections afforded to customers of Beaumont Cornish nor for advising them in relation to the proposed arrangements described in the announcement or any matter referred to in it.

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
NAVBBGDUGDBDGLU
Date   Source Headline
14th Mar 20227:00 amRNSAgronomics Follow on Investment in GALY CO.
8th Mar 20227:00 amRNSAgronomics co-leads SuperMeat’s Series A Financing
24th Feb 20227:00 amRNSAgronomics welcomes Senior Investment Associate
22nd Feb 20227:00 amRNSAgronomics Leads Onego Bio's Seed Funding Round
21st Feb 20228:33 amRNSAgronomics Acquires Stake in Geltor, Inc
3rd Feb 20227:00 amRNSInterim Results
2nd Feb 202212:17 pmRNSResult of AGM
27th Jan 20228:00 amRNSPortfolio Company Update: BlueNalu
10th Jan 20228:12 amRNSExercise of Warrants
24th Dec 202111:51 amRNSHolding(s) in Company
23rd Dec 20211:11 pmRNSHolding(s) in Company
23rd Dec 202110:53 amRNSAgronomics December 2021 Newsletter
21st Dec 20212:29 pmRNSOpen Offer Results Subscription PDMR Dealing & TVR
16th Dec 20217:00 amRNSFinal Results and Notice of AGM
10th Dec 202111:08 amRNSHolding(s) in Company
8th Dec 20218:30 amRNSPortfolio Company Update: The EVERY Company
2nd Dec 20211:30 pmRNSResults of the Placing and Subscription
1st Dec 202111:30 amRNSProposed Fundraise to raise minimum £25 million
19th Nov 20217:00 amRNSAgronomics Leads Ohayo Valley’s Pre-Seed Funding
11th Nov 20217:00 amRNSPortfolio Company Update: Tropic Biosciences
5th Nov 20217:00 amRNSNet Asset Value calculation to 30 September 2021
4th Nov 20217:00 amRNSUS$ 8 million investment in The EVERY Company
3rd Nov 20217:00 amRNSAnnounces Launch of New Website
26th Oct 20217:00 amRNSAgronomics EUR3 million investment in Solar Foods
26th Oct 20217:00 amRNSInSilico Medicine sale-Correction of sale proceeds
20th Oct 20218:00 amRNSAgronomics leads investment in California Cultured
12th Oct 20217:00 amRNSExercise of Warrants and Updated TVR
29th Sep 20217:00 amRNSAnnounces Sale of Oritain Shares
28th Sep 20217:00 amRNSNew Age Meats Announces US$ 25 million Series A
22nd Sep 20212:48 pmRNSPortfolio Company Update: Mosa Meat
20th Sep 20217:00 amRNSAgronomics leads VitroLabs Series A Funding
14th Sep 20217:00 amRNSPortfolio Company Update: BlueNalu
14th Sep 20217:00 amRNSPortfolio Company Update: Meatable
13th Sep 20218:00 amRNSSubscription in Formo’s US $50 million Fundraise
30th Jul 20215:34 pmRNSReplacement: Net Asset Valuation to 30 June 2021
30th Jul 202112:02 pmRNSNet Asset Value calculation to 31 June 2021
21st Jul 20211:15 pmRNSPortfolio Company Update: Shiok Meats Pte. Ltd
15th Jul 20217:00 amRNSWarrants to be traded on J P Jenkins
14th Jul 20217:00 amRNSTwo portfolio companies in XPRIZE semi-finals
13th Jul 20217:00 amRNSHalf Year Newsletter
25th Jun 20214:21 pmRNSPortfolio Company LIVEKINDLY Update
24th Jun 20215:03 pmRNSPortfolio Company Formo Update
24th Jun 20217:00 amRNSAnnounces the Sale of InSilico Medicine Inc Shares
28th May 202112:10 pmRNSResults of General Meeting, Issue of Equity & TVR
28th May 20217:00 amRNSAnnounces the Conversion of CellX SAFE
27th May 20217:00 amRNSBroker Option Results
25th May 20217:00 amRNSUpdate regarding Broker Option
20th May 20217:00 amRNSUpdate regarding Broker Option
13th May 20217:00 amRNSAnnounces Secondary Purchase of Shares in Meatable
12th May 20217:00 amRNSResult of Fundraising

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.